Home News Flu Vaccine Market by Value, by Region, by Segment, and Key Players...

Flu Vaccine Market by Value, by Region, by Segment, and Key Players 2016-2025


United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024 provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an indepth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

  • Hologic
  • Siemen Healthineers
  • Philips Healthcare
  • GE Healthcare
  • Toshiba Medical Systems Corporation

Buy complete research data at:


Long term Growth Projection and Development:

  • Sanofi to Acquire Protein Sciences Corporation
  • It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
  • Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season
  • It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024
  • BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine

Major Flu Vaccines Covered Under This Report Are:

  • Fluzone High Dose
  • Fluzone Quadrivalent
  • Intradermal (ID) Trivalent
  • Vaxigrip
  • Fluarix Quadrivalent
  • Flulaval Quadrivalent
  • Flucelvax Quadrivalent
  • Afluria Quadrivalent
  • Agrippal
  • Fluad
  • Fluvirin
  • Fluvax

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

For More Details Sample/Inquire at:


Key Topics Covered in the Report

Market Overview: United States Flu Vaccine Market (2010 – 2024)
-United States Number of Persons Vaccinated with Flu Vaccine (2010 – 2024)
-United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and -Specification
-Reimbursement & Regulatory System in the US Flu Vaccine Market
-Mergers, Acquisitions, Key Agreements & Collaborations
-Promising Flu Vaccine in Clinical Development
-Flu Vaccine Clinical Trial Insights by Phase, Company & Country
-Key Drivers and Inhibitors of the US Flu Vaccine Market
-Key Companies Analysis

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

The report answers key questions like the market size through 2012-2022 along with the respective growth rates for the various years. The report also studies the market trends for the key competitors and provides their market shares in terms of sales and revenue generated. While forecasting the market and deriving the CAGR the analysts have taken into account the key market drivers, Macro and Micro economic factors, policy and regulatory changes and effect of company policies.

Finally, this report covers the market landscape and its growth prospects over the coming years, the Report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market shares.

Browse Full Report at: 


Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics of Flu Vaccine Market
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a growth map over time to understand the industry growth rate
  • It provides a Five to seven-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future

About Us: –

MarketInsightsReports provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. These reports include in-depth market research studies i.e. market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

+1 (704) 266-3234 sales@marketinsightsreports.com

Connect with us On: